Chuangmin Wu
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 240 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by Amgen at 25.0% of the total. Among family clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 240 payments — averaging $25.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- AstraZeneca$1K
- Boehringer Ingelheim$566
- Lilly USA, LLC$474
- Biohaven Pharmaceutical Holding Company Ltd.$419
- Bayer$291
- plus $2K from 21 others
What the payments were for
- Food & beverage$6,10299%
- Education$611%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 57 | $1,541 |
| AstraZeneca | 22 | $1,069 |
| Boehringer Ingelheim | 28 | $566 |
| Lilly USA, LLC | 27 | $474 |
| Biohaven Pharmaceutical Holding Company Ltd. | 19 | $419 |
| Bayer | 12 | $291 |
| Novo Nordisk | 12 | $246 |
| GSK | 13 | $205 |
| Optinose US, Inc. | 2 | $148 |
| Corcept Therapeutics | 2 | $143 |
| Gilead | 1 | $141 |
| Amarin Pharma, Inc. | 10 | $138 |
| Genentech USA, Inc. | 7 | $127 |
| Galderma Laboratories, L.p. | 1 | $125 |
| Pfizer | 6 | $99 |
| Exact Sciences | 4 | $79 |
| Biohaven Pharmaceuticals, Inc. | 4 | $69 |
| Astellas Pharma US Inc | 1 | $61 |
| AbbVie | 3 | $45 |
| Boston Scientific | 1 | $38 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| Shield Therapeutics Inc | 1 | $24 |
| Eyevance Pharmaceuticals LLC | 1 | $18 |
| Mannkind Corporation | 1 | $17 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Seqirus USA Inc | 1 | $15 |
| Napo Pharmaceuticals Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,163 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Other family in Plano
- Kori NelsonPlano$148K
- Zaineb ShamsPlano$64K
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.